Ticker Scorecard - RYTM Basics Company: Rhythm Pharmaceuticals, Inc. IPO Date: October 5, 2017 Sector: Healthcare Industry: Biotech Market Cap: $3.45B Activated in VL: True Average Daily Range Avg Daily Range: $0.72 | 2.99% Avg Daily Range (30 D): $0.91 | 1.59% Avg Daily Range (90 D): $1.14 | 2.01% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): .36M Avg Daily Volume (90 D): .39M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 48 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 2,218 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $2.2M Avg Inst. Trade (90 D): $2.81M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.87M Avg Closing Trade (30 D): $3.31M Avg Closing Trade (90 D): $3.93M Avg Closing Volume: 101.89K     News Feb 21, 2025 @ 6:00 PM Evolving Landscape of Obesity: Key Market Insights... Source: Delveinsight Oct 24, 2024 @ 10:00 AM Rhythm Pharmaceuticals and Axovia Therapeutics Ann... Source: N/A Oct 8, 2024 @ 8:01 PM Rhythm Pharmaceuticals Announces New Employment In... Source: N/A Sep 16, 2024 @ 8:01 PM Rhythm Pharmaceuticals Announces New Employment In... Source: N/A Jun 28, 2024 @ 12:00 PM Rhythm Pharmaceuticals Receives Positive CHMP Opin... Source: Rhythm Pharmaceuticals, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-4.33 $-.73 $-.55 Diluted EPS $-4.32 $-.73 $-.55 Revenue $ 112.53M $ 33.25M $ 29.08M Gross Profit $ 99.72M $ 29.42M $ 26.13M Net Income / Loss $ -258.94M $ -43.64M $ -32.26M Operating Income / Loss $ -265.51M $ -43.89M $ -40.48M Cost of Revenue $ 12.81M $ 3.83M $ 2.95M Net Cash Flow $ -15.77M $ -113.54M $ 108.54M PE Ratio